Schimmelpennink Evert B. reported CTNM

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001628280-26-045839

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 26, 2026

Published

Jun 26, 2026

Ingested by INSIDER

Nov 5, 03:50 UTC

Last re-read

Nov 5, 03:50 UTC

Extracted facts

Filer

Schimmelpennink Evert B.

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Contineum Therapeutics, Inc. — Stock Option (right to buy)

Ticker

CTNM

Shares

19.0K

Price per share

$0

Execution date (reported)

Jun 26, 2026

Owned after transaction

19.0K shares

Days from execution to publication

0

What this establishes

Schimmelpennink Evert B. filed this Form 4 reporting a grant or award of CTNM on Jun 26, 2026. It became public on Jun 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Schimmelpennink Evert B.cik:0001713795

Issuer

Contineum Therapeutics, Inc.cik:0001855175

Revision history · 0

No field has changed since this record was first ingested.